Teva Pharmaceutical Industries Limited (TEVA) Business News Sept. 09, 2025, 12:30 UTC Teva’s Emrusolmin Granted U.S. FDA Fast Track Designation for Treatment of Multiple System Atrophy Full text
There are no comments here yet...